Quick overview
Job description
Let’s build the future of medicine—together.
Senior Principal Scientist, DMPK (ADME)
YOUR ROLE
As Senior Principal Scientist, DMPK (ADME) at Enveda, you will be the DMPK voice on our discovery projects. You will design and run in vitro and in vivo ADME studies, lead LC-MS/MS bioanalysis, and turn ADME and PK data into clear decisions that help our medicinal chemistry and pharmacology teams move compounds forward faster. Reporting to the Director, ADME, you will stay hands-on at the bench while mentoring and growing the junior scientists in our Hyderabad lab.
WHAT YOU'LL DO
-
Represent DMPK on assigned discovery projects, interpret ADME-SAR and guide chemistry toward better druggability, and contribute to our DMPK strategy for early discovery and lead optimization
-
Design, run and troubleshoot in vitro and in vivo ADME protocols, perform PK analysis (NCA) and use in vitro-in vivo relationships to guide compound progression
-
Lead LC-MS/MS bioanalytical method development and fit-for-purpose qualification for in vitro and in vivo samples
-
Partner with our Non-clinical team on the design and interpretation of PK/PD studies, and present data clearly at internal and external meetings
-
Write and review SOPs, plan day-to-day lab work and instrument use, and mentor and train junior scientists on our assays and technologies
WHAT WE'RE LOOKING FOR
-
PhD in Pharmaceutical Sciences with 8+ years of post-PhD experience in a biotech or CRO discovery DMPK setting
-
Deep hands-on expertise in ADME and bioanalysis, with a proven track record of running in vitro ADME assays, in vivo PK studies and LC-MS/MS method development
-
Strong PK data analysis (NCA) skills using Phoenix WinNonlin or equivalent software
-
Experience guiding and mentoring junior scientists in a laboratory setting, with a strong commitment to lab safety and audit readiness
-
Clear communicator who can turn complex ADME and PK data into practical guidance for chemists and project teams
We hire for trajectory, not just credentials. If you meet most of the above and care deeply about this problem, we want to hear from you.
ABOUT ENVEDA
We recently raised $150M in a Series D, reached unicorn status, and advanced our first drug into Phase 2 trials.
Forbes named us one of America's Best Startup Employers. Newsweek recognized us as a Top 100 Most Loved Workplace.
We're building something rare — and we're just getting started!
Haystack's AI agent can fill in and submit this application for you. How AI auto apply works
Will your resume get past this employer's screening? Check your resume against this job, free
